Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

PanDox: Targeted Doxorubicin in Pancreatic Tumours (PanDox)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04852367
Recruitment Status : Recruiting
First Posted : April 21, 2021
Last Update Posted : August 27, 2021
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2022
Estimated Study Completion Date : December 2022